Peihua Zhao

KU Leuven

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects

Research Interests

Peihua Zhao has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

Alexis Battle
Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA
13 shared publications
Amaia Arruabarrena-Aristorena
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
13 shared publications
Candice Stoudmann
Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, EPFL, Lausanne, Switzerland
13 shared publications
Christina S. Leslie
Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, USA
13 shared publications
Emiliano Cocco
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, USA
13 shared publications
Eneda Toska
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
13 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Immunohistochemical staining of CRPC-SCL models
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S9 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Immunohistochemical staining of CRPC-SCL models
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
KMT2D regulates AR response in AR-high patient derived organoid models and clinical samples from patient cohorts
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S2 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
KMT2D regulates AR response in AR-high patient derived organoid models and clinical samples from patient cohorts
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
AR-low prostate cancer models exhibit loss of AP-1/YAP TAZ binding and a decrease in AR gene expression upon KMT2D knockdown
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S5 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
AR-low prostate cancer models exhibit loss of AP-1/YAP TAZ binding and a decrease in AR gene expression upon KMT2D knockdown
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Mapping single cell transcriptional signatures regulated by KMT2D in AR-low prostate cancer
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S6 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Mapping single cell transcriptional signatures regulated by KMT2D in AR-low prostate cancer
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data 2 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Top enriched pathways upon DHT treatment, PI3K inhibition and the combination with KMT2D knockdown in LNCaP AR-high cells
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Data 2 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Top enriched pathways upon DHT treatment, PI3K inhibition and the combination with KMT2D knockdown in LNCaP AR-high cells
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Data 1 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Top enriched pathways upon DHT treatment and PI3K inhibition in LNCaP AR-high cells
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Data 1 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Top enriched pathways upon DHT treatment and PI3K inhibition in LNCaP AR-high cells
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
AR-low prostate cancer models display loss of AP-1/YAP TAZ binding profiles and downregulation of AR gene expression profiles with KMT2D knockdown
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S4 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
AR-low prostate cancer models display loss of AP-1/YAP TAZ binding profiles and downregulation of AR gene expression profiles with KMT2D knockdown
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
CRPC-SCL models exhibit heterogeneity in lineage marker expression
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S7 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
CRPC-SCL models exhibit heterogeneity in lineage marker expression
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Multiplex Immunofluorescence staining in CRPC-SCL models
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S8 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
Multiplex Immunofluorescence staining in CRPC-SCL models
Open Access
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
KMT2D regulates luminal and stem cell like identity in AR-low prostate cancer
Website
Google Scholar
- 2 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S10 from The Histone Methyltransferase KMT2D Is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration-Resistant Prostate Cancer
by Srushti Kittane, Erik Ladewig, Taibo Li, Jillian R. Love, Ryan Blawski, Yangzhenyu Gao, Amaia Arruabarrena-Aristorena, Peihua Zhao, Susan L. Dalrymple, Huayang Liu, et al.
KMT2D regulates luminal and stem cell like identity in AR-low prostate cancer

Show all